Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 28 points (-0.2%) at 17,094 as of Thursday, Aug. 28, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,204 issues advancing vs. 1,745 declining with 194 unchanged. The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.1%. Top gainers within the industry include Aetna ( AET), up 0.8%, and Humana ( HUM), up 0.5%. On the negative front, top decliners within the industry include Bio-Reference Laboratories ( BRLI), down 9.0%, Mindray Medical International ( MR), down 2.1%, Sirona Dental Systems ( SIRO), down 1.3%, Grifols ( GRFS), down 1.2% and CR Bard ( BCR), down 1.0%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Health Net ( HNT) is one of the companies pushing the Health Services industry higher today. As of noon trading, Health Net is up $0.56 (1.2%) to $46.80 on light volume. Thus far, 245,766 shares of Health Net exchanged hands as compared to its average daily volume of 967,900 shares. The stock has ranged in price between $46.19-$46.87 after having opened the day at $46.21 as compared to the previous trading day's close of $46.24. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Health Net, Inc. provides managed health care services through health plans and government-sponsored managed care plans in the United States. It operates through Western Region Operations and Government Contracts segments. Health Net has a market cap of $3.7 billion and is part of the health care sector. Shares are up 55.9% year-to-date as of the close of trading on Wednesday. Currently there are 4 analysts who rate Health Net a buy, 1 analyst rates it a sell, and 7 rate it a hold. TheStreet Ratings rates Health Net as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Health Net Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.